Medication Review Tool for Personal Injury Claims
A medication review that used to take hours of manual PBS research now takes minutes. AllMeds analyses every medication on a claim for interactions, scheduling, compliance, injury relatedness, and over-prescribing.
What is a medication review?
A structured evaluation of every medication on a claim, designed to surface risks that manual file review consistently misses.
The clinical definition
A medication review is a systematic assessment of all medications a patient is taking. It evaluates whether each drug is clinically appropriate for the diagnosis, checks for dangerous interactions between medications, verifies compliance with prescribing guidelines, and identifies opportunities to simplify or improve the regimen. In healthcare settings, medication reviews are conducted by clinical pharmacists and are a core component of patient safety. The Australian Government funds Home Medicines Reviews and Residential Medication Management Reviews specifically because unreviewed medication regimens are a leading cause of preventable harm.
Why it matters for non-clinicians
Case managers, rehabilitation providers, and insurance assessors are not pharmacists, but they are the people making decisions about claims where medications drive outcomes. A claimant on eight medications may be experiencing side effects that mimic injury symptoms, interactions that impair rehabilitation, or over-prescribing that extends the claim duration. Without a medication review, these issues remain invisible in the file. AllMeds translates clinical medication analysis into plain-language reports that non-clinicians can act on: flag this with the treating doctor, request a tapering plan, escalate for specialist review, or approve as clinically appropriate.
What AllMeds reviews
Six dimensions of medication analysis, covering every aspect that affects claim outcomes and claimant safety.
| Review Area | What It Checks | Why It Matters |
|---|---|---|
| Drug Classification | Verifies each medication's therapeutic class, TGA scheduling (S2 through S8), and active ingredient against 100,000+ registered drugs. Identifies brand name and generic equivalents. | Ensures every medication is correctly identified and classified. Catches instances where the same active ingredient is prescribed under different brand names, creating unintended therapeutic duplication. |
| Interactions | Cross-references every medication pair against TGA, FDA, and MHRA interaction databases. Assigns severity ratings: severe, moderate, or mild. Identifies specific interaction types including CNS depression, serotonin syndrome, respiratory depression, and QT prolongation. | Drug interactions are the most common preventable adverse event in polypharmacy. A single undetected opioid-benzodiazepine interaction can result in respiratory failure. Interaction checking across the full regimen catches combinations that no individual prescriber would see. |
| Scheduling and Compliance | Evaluates prescribing against 15 Australian Safety Standards criteria. Checks opioid duration against acute phase guidelines, Schedule 8 permit requirements, S34 review triggers, and state-specific controlled substance regulations. | Compliance failures create liability exposure for insurers and employers. Extended opioid prescriptions without tapering plans, missing Schedule 8 permits, and uncoordinated prescribing are preventable issues that AllMeds identifies automatically. |
| Injury Relatedness | Assesses whether each medication is clinically appropriate for the compensable injury. Identifies medications for pre-existing conditions versus injury-related treatment. Flags medications with no clear clinical rationale for the injury type. | In workers compensation and CTP claims, only injury-related medications are compensable. Identifying which medications relate to the injury versus pre-existing conditions helps case managers make accurate liability determinations and avoid paying for unrelated treatment. |
| Over-Prescribing | Detects therapeutic duplication, dose escalation beyond recommended thresholds, prescribing duration that exceeds clinical guidelines, and medications prescribed at doses higher than indicated for the injury severity. Identifies multiple prescriber patterns. | Over-prescribing extends claim duration, increases medication costs, and creates dependency risk. Detecting it early allows case managers to coordinate with treating teams before the prescribing pattern becomes entrenched. Over-prescribing is a leading indicator of claims that will become long-tail. |
| Polypharmacy | Calculates cumulative sedation load, anticholinergic burden, and falls risk across the entire regimen. Flags when the total medication count exceeds polypharmacy thresholds. Identifies deprescribing opportunities. | When five or more medications are prescribed concurrently, the risk of adverse events increases exponentially. Polypharmacy assessment looks at the regimen as a whole rather than individual drugs, catching cumulative risks that single-medication analysis misses. |
Who needs medication reviews in PI claims
Three key roles use medication reviews to make better decisions on claims. Each needs different information from the same analysis.
Case managers reviewing claim files
Case managers are the front line of claims management, and the medication list is often the most information-dense and least understood document in the file. A medication review gives case managers immediate visibility into which drugs are high-risk, which combinations are dangerous, which prescriptions have exceeded guidelines, and which medications are unrelated to the compensable injury. Instead of spending hours researching individual drugs on the PBS, case managers get a structured report that tells them exactly what needs attention and what the recommended next step is for each flagged issue.
Rehab providers assessing recovery barriers
Rehabilitation providers frequently encounter claimants who are not progressing as expected, and the reason is often pharmacological rather than physical. A medication review identifies sedation load that prevents participation in physiotherapy, cognitive impairment from anticholinergic burden that interferes with vocational retraining, and side effects that mimic or exacerbate injury symptoms. When the medication regimen is the barrier to recovery, the rehab provider needs evidence to bring to the treating doctor. AllMeds provides that evidence in a format that supports clinical conversations about regimen optimisation.
Insurers auditing medication spend
Medication costs are a significant component of long-tail claim expenses, but raw dispensing data does not tell the full story. A medication review identifies over-prescribing where cheaper alternatives exist, therapeutic duplication where two drugs from the same class are prescribed unnecessarily, non-injury-related medications that should not be compensable, and prescribing patterns that indicate the claim is trending toward chronicity. Insurers and scheme agents use medication reviews to support evidence-based decisions about treatment approvals, expenditure governance, and early intervention strategies.
How it works
Three steps from medication list to a complete review report. No clinical expertise required.
Upload the medication list
Upload the claimant's medication list, pharmacy dispensing history, PBS records, clinical letters, or treating doctor correspondence. AllMeds accepts PDFs, images, spreadsheets, and typed lists. The system uses AI extraction to identify every medication automatically, including brand names, generic equivalents, dosages, frequencies, and prescribing dates. You do not need to reformat or clean the data first.
AI analyses every medication
AllMeds runs six parallel analyses on the full medication list: drug classification and scheduling, interaction checking across every pair, compliance evaluation against 15 safety criteria, injury relatedness assessment, over-prescribing detection, and polypharmacy risk scoring. Each medication is checked against TGA, FDA, and MHRA databases. The entire analysis completes in under two minutes regardless of how many medications are on the list.
Download the structured report
The output is a comprehensive medication review report formatted for direct inclusion in claim files. Each identified issue includes a severity rating, clinical explanation in plain language, and a recommended next step: approve as appropriate, discuss with the treating doctor, request a specialist review, or escalate to the scheme agent. Reports can be shared with treating practitioners, insurers, legal teams, and independent medical examiners.
The time saving
A side-by-side comparison of manual medication review versus AllMeds, showing where the hours go.
Manual review
- Drug identification: 20 to 30 minutes looking up each medication on the PBS, checking brand name vs generic, verifying the drug class
- Interaction checking: 30 to 60 minutes cross-referencing medications in pairs using drug interaction databases or MIMS
- Compliance verification: 20 to 40 minutes checking Schedule 8 regulations, opioid duration guidelines, and state-specific requirements
- Injury relatedness: 15 to 30 minutes assessing whether each medication relates to the compensable injury
- Report writing: 30 to 60 minutes drafting findings into a file note or report for the claim
- Total per 10 claims: 20 to 40 hours of case manager time per week
AllMeds review
- Upload: 30 seconds to upload the medication list, PBS history, or clinical letter
- AI analysis: 60 to 90 seconds for AllMeds to run all six review dimensions simultaneously
- Report generation: Automatic, formatted for direct inclusion in the claim file
- All checks included: Interactions, compliance, scheduling, injury relatedness, over-prescribing, and polypharmacy in one pass
- Consistency: Every review follows the same 15-criteria framework, eliminating variability between reviewers
- Total per 10 claims: Under 20 minutes, freeing 19+ hours per week for higher-value case management
Frequently asked questions
What is a medication review?
A medication review is a systematic evaluation of all medications a person is taking. It assesses whether each drug is appropriate for the diagnosis, safe in combination with other medications, and compliant with prescribing guidelines. In personal injury claims, a medication review also determines whether medications are related to the compensable injury, identifies over-prescribing, and flags regulatory compliance issues. AllMeds automates this process by analysing the full medication list against TGA, FDA, and MHRA databases and producing a structured report with actionable recommendations.
How long does a medication review take?
With AllMeds, a comprehensive medication review takes approximately two minutes from upload to completed report. This includes drug classification, interaction checking across every pair, compliance evaluation against 15 safety criteria, injury relatedness assessment, over-prescribing detection, and polypharmacy risk scoring. Traditional manual reviews by pharmacists or clinical consultants can take two to four hours per claim and often require days or weeks for turnaround. Formal independent pharmacist reviews can cost $300 to $800 per assessment.
Who does medication reviews in claims management?
Traditionally, medication reviews in claims management are performed by clinical pharmacists, independent medical examiners, or case managers with clinical backgrounds. The challenge is that most case managers are not pharmacists, and the volume of claims requiring medication review far exceeds the capacity of available clinical resources. AllMeds enables any case manager, rehabilitation provider, or scheme assessor to generate a clinical-grade medication review without requiring pharmacological expertise. The platform handles the analysis; the user handles the decision.
What does a medication review include?
An AllMeds medication review includes six areas of analysis: drug classification and TGA scheduling verification, interaction checking across every medication combination with severity ratings, compliance evaluation against 15 Australian Safety Standards criteria including opioid duration and Schedule 8 requirements, injury relatedness assessment for each medication, over-prescribing detection including therapeutic duplication and dose escalation, and polypharmacy risk scoring with sedation load and anticholinergic burden calculation. Each flagged issue includes a plain-language explanation and recommended next step.
Can AllMeds replace a pharmacist review?
AllMeds is designed to complement clinical pharmacist reviews, not replace them entirely. The platform delivers the same analytical rigour for drug interactions, compliance checking, and risk scoring, but in minutes rather than days. For straightforward claims with standard medication regimens, an AllMeds review may be sufficient. For complex cases involving unusual drug combinations, dose titration decisions, or formal deprescribing protocols, AllMeds provides the evidence base that enables more focused and efficient pharmacist consultations. Many organisations use AllMeds as a screening tool across all claims, escalating only the highest-risk cases for formal pharmacist or IME review.
Review medications on your next claim in minutes
See how AllMeds analyses every medication for interactions, compliance, injury relatedness, and risk, and delivers a structured report you can act on immediately.
Book a Demo